Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol

被引:41
作者
Mucalo, Iva [1 ]
Hadziabdic, Maja Ortner [1 ]
Brajkovic, Andrea [1 ]
Lukic, Sonja [2 ]
Maric, Patricia [2 ]
Marinovic, Ivana [3 ]
Bacic-Vrca, Vesna [1 ,3 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Ctr Appl Pharm, A Kovacica 1, Zagreb 10000, Croatia
[2] Univ Zagreb, Fac Pharm & Biochem, A Kovacica 1, Zagreb 10000, Croatia
[3] Univ Hosp Dubrava, Dept Clin Pharm, Av Gojka Suska 6, Zagreb 10000, Croatia
关键词
Polypharmacy; Potentially inappropriate medicines; EU(7)-PIM list; STOPP version 2 criteria; Comprehensive protocol; ADVERSE DRUG-REACTIONS; EMERGENCY-DEPARTMENT VISITS; MEDICATION USE; OLDER-ADULTS; BEERS CRITERIA; SCREENING TOOL; CONSENSUS PANEL; STOPP/START CRITERIA; EXPLICIT CRITERIA; GENERAL-PRACTICE;
D O I
10.1007/s00228-017-2246-y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to measure the prevalence of potentially inappropriate medications (PIMs) by using the EU(7)-PIM list, STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions) version 2 criteria and the new comprehensive protocol. This prospective study involved a sample of 276 consecutive elderly patients discharged from the university teaching hospital. Age, gender, diagnoses, medication history and medicines at discharge were recorded. The main outcome measure was the prevalence of PIMs according to each set of criteria: EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. The median patient age (range) was 74 (65-92) years. The median number of prescribed medications was 7 (1-17). STOPP identified 393 PIMs affecting 190 patients (69%), EU(7)-PIM list identified 330 PIMs in 184 patients (66.7%) whilst the comprehensive protocol identified 134 PIMs in 102 patients (37%). STOPP version 2 criteria identified significantly more PIMs per patient than the other two protocols (p < 0.001). Gender (p = 0.002), glomerular filtration rate (p = 0.039) and number of comorbidities (p = 0.001) were associated with the proportion of PIMs for the STOPP version 2 criteria only. A very high PIM prevalence at discharge was reported suggesting the urgent need for actions to reduce them. STOPP version 2 criteria identified significantly more PIMs than the EU(7)-PIM list and the comprehensive protocol and was found as a more sensitive tool for PIM detection.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 50 条
  • [41] Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria
    Lorena de Agustín Sierra
    Jaime Rodríguez Salazar
    Ana Belén Jiménez-Muñoz
    María Jesús Molina Hernández
    Paloma Bermejo Bescós
    Irene Iglesias Peinado
    Benito García Díaz
    European Journal of Clinical Pharmacology, 2021, 77 : 757 - 766
  • [42] Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria
    de Agustin Sierra, Lorena
    Rodriguez Salazar, Jaime
    Jimenez-Munoz, Ana Belen
    Molina Hernandez, Maria Jesus
    Bermejo Bescos, Paloma
    Iglesias Peinado, Irene
    Garcia Diaz, Benito
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 757 - 766
  • [43] Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version
    Blanco-Reina, Encarnacion
    Garcia-Merino, Maria Rosa
    Ocana-Riola, Ricardo
    Aguilar-Cano, Lorena
    Valdellos, Jennifer
    Bellido-Estevez, Inmaculada
    Ariza-Zafra, Gabriel
    PLOS ONE, 2016, 11 (12):
  • [44] An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list
    Sonnerstam, Eva
    Sjolander, Maria
    Gustafsson, Maria
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (06) : 735 - 742
  • [45] Prevalence, determinants, and health outcomes of potentially inappropriate medication use according to the 2023 beers criteria among hospitalised older patients
    Jenghua, Kittipak
    Phatthanasobhon, Sirayut
    Poolpun, Duangkamon
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2025, 129
  • [46] Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients-An Observational Retrospective Study
    Sipos, Mariana
    Farcas, Andreea
    Leucuta, Daniel Corneliu
    Bulik, Noemi-Beatrix
    Huruba, Madalina
    Dumitrascu, Dan
    Mogosan, Cristina
    PHARMACEUTICALS, 2023, 16 (06)
  • [47] Potentially Inappropriate Prescribing Identified Using STOPP/START Version 3 in Geriatric Patients and Comparison with Version 2: A Cross-Sectional Study
    Szoszkiewicz, Mikolaj
    Deskur-Smielecka, Ewa
    Styszynski, Arkadiusz
    Urbanska, Zofia
    Neumann-Podczaska, Agnieszka
    Wieczorowska-Tobis, Katarzyna
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [48] GheOP3S tool and START/STOPP criteria version 2 for screening of potentially inappropriate medications and omissions in nursing home residents
    Stojanovic, Marko
    Vukovic, Milica
    Jovanovic, Milan
    Dimitrijevic, Srdan
    Radenkovic, Miroslav
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (01) : 158 - 164
  • [49] Potentially inappropriate prescribing (PIP) in long-term care (LTC) patients: validation of the 2014 STOPP-START and 2012 Beers criteria in a LTC populationa protocol for a cross-sectional comparison of clinical and health administrative data
    Bjerre, Lise M.
    Halil, Roland
    Catley, Christina
    Farrell, Barbara
    Hogel, Matthew
    Black, Cody D.
    Williams, Margo
    Ryan, Cristin
    Manuel, Douglas G.
    BMJ OPEN, 2015, 5 (10):
  • [50] Optimizing medication therapy in elderly patients: The impact of medication review using STOPP and START criteria version 2
    Murali, Silpa
    Damodaran, Aswin
    Jacob, Namita Maria
    Venugopal, Anjaly
    Johnson, Joveena
    Vijayan, Meenu
    Pavithran, K.
    Sekhar, M. Sonal
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,